Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Scientist Home Future Health EV-to-EBITDA?
Scientist Home Future HealthSHFH +11.11%8 EV-to-EBITDA is -360.45 as of Aug. 23, 2026. GuruFocus rates SHFH with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 515 Healthcare Providers & Services companies, Scientist Home Future Health ranks worse than 194174.56% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Scientist Home Future Health's enterprise value is $118.95 Mil.
Scientist Home Future Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.33 Mil. Therefore, Scientist Home Future Health's EV-to-EBITDA for today is -360.45.
The historical rank and industry rank for Scientist Home Future Health's EV-to-EBITDA or its related term are showing as below:
SHFH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -360.45 Med: -147.41 Max: -137.67
Current: -360.45
During the past 2 years, the highest EV-to-EBITDA of Scientist Home Future Health was -137.67. The lowest was -360.45. And the median was -147.41.
SHFH's EV-to-EBITDA is ranked worse than 100% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.65
vs SHFH: -360.45
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Scientist Home Future Health (OTCPK:SHFH) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Scientist Home Future Health's PE Ratio (TTM) for today is calculated as:
Scientist Home Future Health's share price for today is $5.00.
Scientist Home Future Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.008.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Scientist Home Future Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scientist Home Future Health EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Scientist Home Future Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Scientist Home Future Health's EV-to-EBITDA falls into.
Scientist Home Future Health's current Enterprise Value is $118.95 Mil.
Scientist Home Future Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.33 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scientist Home Future Health (SHFH) has a EV-to-EBITDA of -360.45 as of Aug. 23, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Scientist Home Future Health. According to the industry distribution chart, Scientist Home Future Health ranks #999999 out of 515 companies in the Healthcare Providers & Services industry.
Is Scientist Home Future Health's EV-to-EBITDA too high?
Scientist Home Future Health's current EV-to-EBITDA is -360.45. Based on the distribution chart, Scientist Home Future Health ranks #999999 out of 515 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Scientist Home Future Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Scientist Home Future Health's EV-to-EBITDA compare to BHIC and PETS?
According to the Healthcare Providers & Services industry distribution chart, Scientist Home Future Health ranks #999999 out of 515 companies for EV-to-EBITDA. This places Scientist Home Future Health in the lower half of its industry. The industry median EV-to-EBITDA is 10.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.65, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Scientist Home Future Health. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scientist Home Future Health's current EV-to-EBITDA is -360.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scientist Home Future Health stock overvalued right now?
Scientist Home Future Health (SHFH) has a current EV-to-EBITDA of -360.45. The current EV-to-EBITDA is -360.45. Scientist Home Future Health's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Scientist Home Future Health (SHFH), the current EV-to-EBITDA is -360.45 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Scientist Home Future Health Ltd, through its subsidiaries, engages in the retail trading of health supplements and topical creams and provision of physical check-up services in Hong Kong. It focuses on developing sustainable rehabilitation solutions, particularly for degenerative diseases, ensuring that the products not only address current symptoms but also support future, long-term health and recovery. The company has two reportable segments based on business unit, retail trading and service business. The majority of revenue is derived from the Retail Trading segment, which derives revenue from customers by providing health supplements and topical creams. It has two reportable segments based on geographical location: Hong Kong and Non-Hong Kong; key revenue derives from Hong Kong.
8GF Score
Get the complete analysis for SHFH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHFH has been successfully added to your 
